Gainers

• Traws Pharma (NASDAQ:TRAW) shares increased by 37.0% to $2.33 during Friday's pre-market session. The market value of their outstanding shares is at $17.2 million.
• Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 18.42% to $18.0. The company's market cap stands at $1.6 billion. The company's, Q1 earnings came out yesterday.
• Celldex Therapeutics (NASDAQ:CLDX) stock moved upwards by 12.54% to $37.5. The market value of their outstanding shares is at $2.6 billion. As per the news, the Q1 earnings report came out yesterday.
• InMed Pharmaceuticals (NASDAQ:INM) stock rose 12.0% to $0.78. The company's market cap stands at $2.3 million.
• Progyny (NASDAQ:PGNY) stock moved upwards by 10.17% to $21.11. The company's market cap stands at $1.6 billion. The company's, Q1 earnings came out yesterday.
• Artiva Biotherapeutics (NASDAQ:ARTV) stock increased by 9.82% to $13.75. The company's market cap stands at $307.3 million. As per the news, the Q1 earnings report came out today.

Losers

• Sensus Healthcare (NASDAQ:SRTS) shares decreased by 25.1% to $3.08 during Friday's pre-market session. The company's market cap stands at $67.6 million. As per the news, the Q1 earnings report came out yesterday.
• Absci (NASDAQ:ABSI) stock decreased by 19.66% to $4.62. The company's market cap stands at $893.8 million. The company's, Q1 earnings came out yesterday.
• Amphastar Pharma (NASDAQ:AMPH) shares fell 15.65% to $20.27. The company's market cap stands at $1.0 billion. As per the press release, Q1 earnings came out yesterday.
• Capricor Therapeutics (NASDAQ:CAPR) stock decreased by 13.97% to $29.2. The company's market cap stands at $1.9 billion.
• Organogenesis Holdings (NASDAQ:ORGO) stock fell 13.84% to $2.18. The company's market cap stands at $320.9 million. The company's, Q1 earnings came out yesterday.
• Artivion (NYSE:AORT) shares decreased by 12.5% to $30.99. The company's market cap stands at $1.6 billion. As per the press release, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.